4
Changes in Ownership
Ginkgo Bioworks Holdings, Inc. Filed Acc 0001127602-24-003588
See remarks sold 39,569 shares at $1.21 ($47,799)
- See remarks acquired 85,208 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dmytruk Mark E. See remarks | 2024-02-01 | Option exercise | +65,448 | 781,546 | D | ||
| Dmytruk Mark E. See remarks | 2024-02-01 | Option exercise | +18,125 | 799,671 | D | ||
| Dmytruk Mark E. See remarks | 2024-02-01 | Option exercise | +1,635 | 801,306 | D | ||
| Dmytruk Mark E. See remarks | 2024-02-02 | Sale | −39,569 | $1.21 | $47,799 | 761,737 | D |
| Derivatives | |||||||
| Dmytruk Mark E. See remarks | 2024-02-01 | Option exercise · Restricted Stock Units | −65,448 | 843,335 | D | ||
| Dmytruk Mark E. See remarks | 2024-02-01 | Option exercise · Restricted Stock Units | −18,125 | 670,625 | D | ||
| Dmytruk Mark E. See remarks | 2024-02-01 | Option exercise · Class B Common Stock | −1,635 | 631,957 | D | ||
| Open-market sales · 39,569 sh · avg $1.21 · $47,799 | |||||||
Loading xslF345X05/form4.xml…